Clinical Pharmacologist
Pfizer
Flavia Storelli is a Clinical Pharmacologist at Pfizer Oncology R&D (previously Seagen, since 2022). Prior to that, she was a postdoctoral scholar in the Department of Pharmaceutics of the University of Washington and the lead scientist of the University of Washington Research Affiliate Program on Transporters (UWRAPT, PI: Jashvant Unadkat). Her research there focused on proteomics-informed in vitro in vivo extrapolation of transported-mediated drug disposition (clearance, tissue concentrations). Flavia Storelli completed a PhD in Pharmaceutical Sciences in the Division of Clinical Pharmacology and Toxicology of Geneva University Hospitals (2018, PIs: Youssef Daali and Jules Desmeules), where her research focused on CYP-mediated gene-drug-drug-disease interactions.